RxDoctor Payments DataLook up a doctor →

Caroline Watson, MD

Ophthalmology · Huntsville, ALNPI 1144756875

Payments from drug & device makers

$292,308in general payments, 2019–2025

Across 459 payments — averaging $636.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tarsus Pharmaceuticals, Inc.$90K
  • Bausch & Lomb Americas Inc.$42K
  • Johnson & Johnson Surgical Vision, Inc.$40K
  • Alcon$30K
  • Biotissue Holdings Inc.$28K
  • Dompe US, Inc.$17K
  • plus $44K from 20 others
$9in research payments, 2019–2025

Across 1 payment — averaging $9.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$9

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$292,308 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.

See all ophthalmology providers in Alabama

Medicare billing

Part B allowed, 2024
$281,932
Medicare patients
351
Services billed
1,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →